Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors. (Q55006314)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors. |
scientific article |
Statements
Phase Ib Study of Safety and Pharmacokinetics of the PI3K Inhibitor SAR245408 with the HER3-Neutralizing Human Antibody SAR256212 in Patients with Solid Tumors (English)
Carlos L Arteaga
Vandana G Abramson
Jeffrey G Supko
James M Cleary
John F Hilton
Nicole G Chau
Daniel C Cho
Joseph Pearlberg
Joanne Lager
Geoffrey I Shapiro
28 December 2016